Pancreatic Insufficiency
25
3
4
16
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
4.0%
1 terminated out of 25 trials
94.1%
+7.6% vs benchmark
28%
7 trials in Phase 3/4
38%
6 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (25)
Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy
Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis
MRI to Characterize and Predict CF Liver Disease in PUSH Cohort
PERT to Improve Quality of Life in Patients Undergoing Pancreaticoduodenectomy: A Pilot Randomized Controlled Trial
Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI)
Hypoglycemia and Glucagon Response in CF
Effect of Chronic Incretin-based Therapy in Cystic Fibrosis
Equivalence Study to Compare Two Strengths of Creon in China
PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer
Pancreatic Exocrine Insufficiency After Bariatric Surgery
Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis
Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)
Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency
Pancreatic Insufficiency Secondary to Tobacco Exposure
Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI